Authors:
Provides detailed coverage of the practical pharmacology of symptomatic drugs for Alzheimer’s disease
Written by the leading experts in donepezil, galantamine, rivastigmine, and memantine
Offers a sound basis for optimal clinical use of the drugs?
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (6 chapters)
-
Front Matter
-
Back Matter
About this book
In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimer’s disease. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs for dementia are used.
The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. The failure of clinical trials of these drugs to yield satisfactory results has, however, meant that for the time being patients continue to be treated only with symptomatic drugs. There is accordingly a need to become more proficient in the use of symptomatic medicines, and it is against the background of this quest that Practical Pharmacology for Alzheimer’s Disease will be of wide interest.
Reviews
“Written by four experts in dementia research, this book describes the pharmacology of the four symptomatic drugs used in the treatment of Alzheimer's disease. It provides an overview of the basic theories of the pharmacology of Alzheimer's disease and the way in which the medications are used for the treatment of dementia. … book is most suitable for geriatric psychiatrists, geriatric medicine specialists, and neurologists who spend a significant amount of time treating people with Alzheimer's disease and other dementias.” (Danielle L. Anderson, Doody's Book Reviews, June, 2016)
Authors and Affiliations
-
Toyonaka, Japan
Takashi Kudo
-
New York, USA
Kenneth L. Davis
-
Barcelona, Spain
Rafael Blesa Gonzalez
-
Southhampton, United Kingdom
David George Wilkinson
About the authors
Dr. Kenneth Davis, Mount Sinai Medical Center, New York, NY 10029, USA
Dr. Rafael Blesa Gonzalez, Autonomous University of Barcelona, Barcelona, Spain
Dr. David George Wilkinson, University of Southampton, Southampton, United Kingdom
Bibliographic Information
Book Title: Practical Pharmacology for Alzheimer’s Disease
Authors: Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson
DOI: https://doi.org/10.1007/978-3-319-26206-2
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-26204-8Published: 19 February 2016
Softcover ISBN: 978-3-319-79906-3Published: 30 March 2018
eBook ISBN: 978-3-319-26206-2Published: 10 February 2016
Edition Number: 1
Number of Pages: VIII, 141
Number of Illustrations: 9 b/w illustrations, 18 illustrations in colour
Topics: Psychopharmacology, Neurology, Pharmacotherapy